CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-26 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,101 | $121.29 | $134K | 2,052,209 |
| 2023-07-19 | AFEYAN NOUBAR Director | Sale 10b5-1 | −847 | $124.14 | $105K | 2,081,362 |
| 2023-07-19 | AFEYAN NOUBAR Director | Sale 10b5-1 | −9,004 | $125.26 | $1.1M | 2,072,358 |
| 2023-07-19 | AFEYAN NOUBAR Director | Sale 10b5-1 | −5,149 | $126.08 | $649K | 2,067,209 |
| 2023-07-17 | Hoge Stephen President | Sale 10b5-1 | −15,000 | $120.60 | $1.8M | 1,602,303 |
| 2023-07-12 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,990 | $124.59 | $248K | 2,095,219 |
| 2023-07-12 | AFEYAN NOUBAR Director | Sale 10b5-1 | −5,865 | $125.61 | $737K | 2,089,354 |
| 2023-07-12 | AFEYAN NOUBAR Director | Sale 10b5-1 | −6,845 | $126.27 | $864K | 2,082,509 |
| 2023-07-12 | AFEYAN NOUBAR Director | Sale 10b5-1 | −300 | $127.15 | $38K | 2,082,209 |
| 2023-07-05 | AFEYAN NOUBAR Director | Sale 10b5-1 | −3,533 | $123.46 | $436K | 2,108,676 |
| 2023-07-05 | AFEYAN NOUBAR Director | Sale 10b5-1 | −6,097 | $124.17 | $757K | 2,102,579 |
| 2023-07-05 | AFEYAN NOUBAR Director | Sale 10b5-1 | −2,639 | $125.15 | $330K | 2,099,940 |
| 2023-07-05 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,012 | $126.54 | $128K | 2,098,928 |
| 2023-07-05 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,549 | $127.55 | $198K | 2,097,379 |
| 2023-07-05 | AFEYAN NOUBAR Director | Sale 10b5-1 | −170 | $128.17 | $22K | 2,097,209 |
| 2023-06-28 | Bancel Stephane Chief Executive Officer | Exercise or conversion 10b5-1 | +27,155 | $0.99 | $27K | 5,439,101 |
| 2023-06-28 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −2,278 | $120.39 | $274K | 5,436,823 |
| 2023-06-28 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −11,417 | $121.40 | $1.4M | 5,425,406 |
| 2023-06-28 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −13,094 | $122.01 | $1.6M | 5,412,312 |
| 2023-06-28 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −366 | $123.05 | $45K | 5,411,946 |
Page 41 of 66 · 1,314 trades